Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 83 publications
Correction: Targeting the vasopressin type-2 receptor for renal cell carcinoma therapy.
Journal: Oncogene
Published: January 27, 2025
Author Correction: A high-throughput screening platform for Polycystic Kidney Disease (PKD) drug repurposing utilizing murine and human ADPKD cells.
Journal: Scientific reports
Published: October 13, 2022
A Novel Renoprotective Strategy: Upregulation of PD-L1 Mitigates Cisplatin-Induced Acute Kidney Injury.
Journal: International journal of molecular sciences
Published: October 18, 2021
Can kidney parenchyma metabolites serve as prognostic biomarkers for long-term kidney function after nephrectomy for renal cell carcinoma? A preliminary study.
Journal: Clinical kidney journal
Published: March 24, 2020
Introduction: Why Do We Need a Special Volume on Kidney Cancer?
Journal: Seminars in nephrology
Published: March 05, 2020
Ultramarathon Plasma Metabolomics: Phosphatidylcholine Levels Associated with Running Performance.
Journal: Sports (Basel, Switzerland)
Published: February 18, 2020
The Cell-Cycle Regulatory Protein p21CIP1/WAF1 Is Required for Cytolethal Distending Toxin (Cdt)-Induced Apoptosis.
Journal: Pathogens (Basel, Switzerland)
Published: November 14, 2019
A high-throughput screening platform for Polycystic Kidney Disease (PKD) drug repurposing utilizing murine and human ADPKD cells.
Journal: Scientific reports
Published: August 07, 2019
Translating L-2-HG to kidney cancer at the bench and bedside.
Journal: Annals of translational medicine
Published: February 12, 2019
Plasma metabolites and lipids associate with kidney function and kidney volume in hypertensive ADPKD patients early in the disease course.
Journal: BMC nephrology
Published: November 19, 2018
Translating Metabolic Reprogramming into New Targets for Kidney Cancer.
Journal: Kidney cancer (Clifton, Va.)
Published: October 19, 2018
Last Updated: 09/26/2026